Often state-run, these organisations suffer no commercial loss from being slow or late in delivering agreed power infrastructure.

We developed a particular set of tools and an approach that over time became what we now refer to as Design to Value.As we have evolved this approach over the years, we’ve extended it to include many more pharmaceutical engineering projects, as well as a wide range of other sectors, from heavy industry to prisons.. Part of our role is to act as pharmaceutical plant design consultants.

What we aim to do is make sure that projects are well aligned with business requirements; to define and design future assets that translate a company’s strategic objectives into tangible manufacturing facilities – and provide added value.The key point here is that we put a great deal of effort into defining the business needs.That is, after all, why we're doing the project.. We also invest effort into constantly assessing how well our design solutions match those needs.

This has often resulted in solutions that require no capital expenditure at all, because we find different ways of meeting the requirements..The Design to Value approach relies fundamentally on close collaboration between a wider range of experts than is seen in conventional projects, particularly including business functions.

These experts are actively involved in the definition and search for solutions on an equal footing with the engineering and architectural people who would normally be considered part of the project team.. We also use an iterative approach to pharmaceutical facility design, recognising that good solutions emerge from exploration of all the options.

So our chances of finding the optimum solution are increased when compared to more linear design approaches..New South Wales has done a comprehensive study over the last two years leading with their Design for Manufacturing and Assembly (DfMA) guidelines for schools that go beyond volumetric towards a platform-based approach.

In Queensland, there’s been a recent expression of interest released to find out how they can utilise MMC to build more affordable and social housing.. States are talking about DfMA and MMC but taking different approaches and not necessarily sharing knowledge and insights.. 2.Start-ups will rise up.. A component-based platform approach will help engage local manufacturing.

We will see smaller manufacturers of repeat components getting engaged in the supply chain rather than just being a few big players producing the majority of a building.This has numerous socioeconomic advantages.